Clinical trials: Naltrexone
Naltrexone, Placebo
Understanding How Opioids Affect the Experiential and Neural Signatures of Social Experiences
The study is a randomized, placebo-controlled design with the opioid antagonist, oral naltrexone. Following random assignment, participants will take 50mg of naltrexone or placebo once a day for 7 days.
- Trial name
- NCT05007561
- Testing
- Naltrexone Hydrochloride
- Where
- United States
- Volunteers
- 217 people, healthy volunteers welcome
- Sponsor
- San Diego State University
Naltrexone HCl 50 MG Oral Tablet, Placebo
Naltrexone for Prolonged Grief Disorder
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social…
- Trial name
- NPGD (NCT06140420)
- Testing
- Naltrexone Oral Product
- Where
- United States
- Volunteers
- 7 people, healthy volunteers welcome
- Sponsor
- Texas Tech University
Interstitial Cystitis, Painful Bladder Syndrome
IC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone
Interstitial cystitis/painful bladder syndrome (IC/PBS) is a debilitating condition with symptoms of urinary urgency, frequency, nocturia (waking up at night to void), and pain, without evidence of urinary tract infection or…
- Conditions
- Interstitial Cystitis, Painful Bladder Syndrome, Bladder Pain Syndrome, Low Dose Naltrexone
- Trial name
- NCT04313972
- Testing
- low-dose naltrexone
- Where
- United States
- Volunteers
- 3 people, healthy volunteers welcome
- Sponsor
- Endeavor Health
Eye Tracking, Gambling Disorder
RCT for Gambling and Naltrexone, Using Use Eye-tracking Analysis to Predict Treatment Response
The primary objective of this study is to determine whether favorable response to naltrexone orally taken in treatment of GD can be predicted by patterns of visual scanning, assessed by eye-tracking technology before, at the…
- Conditions
- Eye Tracking, Gambling Disorder, Naltrexone
- Trial name
- NCT04738773
- Testing
- Naltrexone
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- University of Sao Paulo
Naltrexone, Methylphenidate Abuse
Study for Naltrexone on the Abuse Potential of Methylphenidate
The current abuse liability study aims to assess the potential for co-administration of naltrexone (NTX) to reduce the abuse potential of methylphenidate (MPH).
- Trial name
- NCT03769064
- Testing
- Methylphenidate 60 mg, Treatment Phase Sequence 4213, Treatment Phase Sequence 2134
- Where
- United States
- Volunteers
- 94 people, healthy volunteers welcome
- Sponsor
- Avekshan LLC